Related Experiment Video
Updated: Jun 23, 2025
07:49
Measuring Local Anaphylaxis in Mice
Published on: October 14, 2014
19.4K
Anaphylaxis biomarkers: present and future
European Annals of Allergy and Clinical Immunology
|June 26, 2024
Summary
Anaphylaxis, a severe allergic reaction, is diagnosed clinically. Biomarkers are being studied to improve diagnosis, risk assessment, and treatment strategies for this life-threatening condition.
Area of Science:
- Immunology
- Allergy and Clinical Immunology
- Biochemistry
Background:
- Anaphylaxis is a critical, rapid-onset systemic hypersensitivity.
- Current diagnosis relies heavily on clinical presentation.
- Understanding anaphylaxis mechanisms and biomarkers is crucial.
Purpose of the Study:
- To review current data on potential anaphylaxis biomarkers.
- To explore the clinical utility of these biomarkers.
- To discuss future perspectives for biomarker application.
Main Methods:
- Literature review of studies on anaphylaxis biomarkers.
- Analysis of immune and non-immune mediators.
- Evaluation of diagnostic and prognostic potential.
Main Results:
- Biomarkers offer potential for improved diagnosis and risk stratification.
- Various mediators are under investigation as potential biomarkers.
- Clinical application of biomarkers is still evolving.
Conclusions:
- Biomarkers may enhance anaphylaxis management significantly.
- Further research is needed to validate and implement biomarkers.
- Biomarkers could revolutionize anaphylaxis prevention and treatment.
Related Concept Videos
02:06Allergic Reactions
27.3K
Overview
27.3K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
270
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
270
00:42Cross-reactivity
31.0K
Overview
31.0K
01:10Antibody Structure
59.9K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
59.9K
01:27Allergic Drug Reactions
832
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
832
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
76
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
76